STLNW (Starling Oncology) OCF Margin %: -1.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STLNW Starling Oncology Inc STLNW
61 GF Score
Price $0.06
! 4 Warning Signs
View Full Analysis

What is Starling Oncology OCF Margin %?

Starling Oncology STLNW 61 OCF Margin % is -1.50% as of Mar. 2026. GuruFocus rates STLNW with a GF Score™ of 61/100. The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Starling Oncology ranks worse than 77.59% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Starling Oncology's Cash Flow from Operations for the three months ended in Mar. 2026 was $-2.22 Mil. Starling Oncology's Revenue for the three months ended in Mar. 2026 was $147.44 Mil. Therefore, Starling Oncology's OCF Margin % for the quarter that ended in Mar. 2026 was -1.50%.

As of today, Starling Oncology's current OCF Yield % is -157,000.00%.

The historical rank and industry rank for Starling Oncology's OCF Margin % or its related term are showing as below:


During the past 8 years, the highest OCF Margin % of Starling Oncology was 4.99%. The lowest was -24.46%. And the median was -5.82%.

STLNW's OCF Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.27
* Ranked among companies with meaningful OCF Margin % only.

Starling Oncology OCF Margin % Related Terms

Starling Oncology OCF Margin % Historical Data

* Premium members only.

The historical data trend for Starling Oncology's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Starling Oncology OCF Margin % Chart

Starling Oncology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -16.10 -24.46 -11.20 -6.75 -4.89

Starling Oncology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.78 -8.52 -9.25 2.28 -1.50
STLNW
61GF Score
Starling Oncology Inc STLNW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Starling Oncology OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Starling Oncology's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-24.587/502.729
=-4.89 %

Starling Oncology's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.215/147.441
=-1.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1.50% mean?
Starling Oncology (STLNW) has a OCF Margin % of -1.50% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Starling Oncology and its competitors. According to the industry distribution chart, Starling Oncology ranks #516 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 77.6%.
Is Starling Oncology's OCF Margin % too high?
Starling Oncology's current OCF Margin % is -1.50%. Based on the distribution chart, Starling Oncology ranks #516 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Starling Oncology has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Starling Oncology's OCF Margin % compare to SRTA and CCRN?
According to the Healthcare Providers & Services industry distribution chart, Starling Oncology ranks #516 out of 665 companies for OCF Margin %. This places Starling Oncology in the lower half of its industry. The industry median OCF Margin % is 8.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Starling Oncology and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Starling Oncology's current OCF Margin % is -1.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Starling Oncology stock overvalued right now?
Starling Oncology (STLNW) has a current OCF Margin % of -1.50%. The current OCF Margin % is -1.50%. Starling Oncology's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Starling Oncology (STLNW), the current OCF Margin % is -1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Starling Oncology Business Description

Other Exchanges TOI:USA
Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
61GF Score

Get the complete analysis for STLNW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price